474
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluation

Cenobamate for the treatment of focal epilepsies

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 2215-2223 | Received 03 Jul 2020, Accepted 28 Jul 2020, Published online: 19 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gaetano Zaccara, Simona Lattanzi, Antonio Leo & Emilio Russo. (2021) Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults. Neuropsychiatric Disease and Treatment 17, pages 3447-3457.
Read now
James W. Wheless. (2020) Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review. Expert Review of Neurotherapeutics 20:11, pages 1085-1098.
Read now

Articles from other publishers (11)

Jamir Pitton Rissardo & Ana Letícia Fornari Caprara. (2023) Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature. Medicina 59:8, pages 1389.
Crossref
Anna-Lena Friedo, Benedikt Greshake, Konstantin L. Makridis & Hans-Beatus Straub. (2023) Cenobamate significantly improves seizure control in intellectually disabled patients with drug-resistant epilepsy and allows drug load reduction. Frontiers in Neurology 14.
Crossref
Maria Antonietta Barbieri, Emilio Perucca, Edoardo Spina, Paola Rota & Valentina Franco. (2023) Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy. CNS & Neurological Disorders - Drug Targets 22:3, pages 394-403.
Crossref
Chao Wu, Baode Ma, Gen-Qiang Chen & Xumu Zhang. (2022) Highly efficient and enantioselective synthesis of β-heteroaryl amino alcohols via Ru-catalyzed asymmetric hydrogenation . Chemical Communications 58:91, pages 12696-12699.
Crossref
Adam Strzelczyk & Susanne Schubert-Bast. (2022) Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies. CNS Drugs 36:10, pages 1079-1111.
Crossref
Eunsol Yang, Jung Sunwoo, Ki Young Huh, Yu Kyong Kim, SeungHwan Lee, In‐Jin Jang & Kyung‐Sang Yu. (2021) Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non‐Japanese. Clinical and Translational Science 15:2, pages 490-500.
Crossref
Laurent M. Willems, Felix Rosenow, Susanne Schubert-Bast, Gerhard Kurlemann, Johann Philipp Zöllner, Thomas Bast, Astrid Bertsche, Ulrich Bettendorf, Daniel Ebrahimi-Fakhari, Janina Grau, Andreas Hahn, Hans Hartmann, Christoph Hertzberg, Frauke Hornemann, Ilka Immisch, Julia Jacobs, Karl Martin Klein, Kerstin A. Klotz, Gerhard Kluger, Susanne Knake, Markus Knuf, Klaus Marquard, Thomas Mayer, Sascha Meyer, Hiltrud Muhle, Karen Müller-Schlüter, Felix von Podewils, Susanne Ruf, Matthias Sauter, Hannah Schäfer, Jan-Ulrich Schlump, Steffen Syrbe, Charlotte Thiels, Regina Trollmann, Adelheid Wiemer-Kruel, Bernd Wilken, Bianca Zukunft & Adam Strzelczyk. (2021) Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients’ Perspectives. CNS Drugs 35:10, pages 1107-1122.
Crossref
Nicola Specchio, Nicola Pietrafusa & Federico Vigevano. (2021) Is Cenobamate the Breakthrough We Have Been Wishing for?. International Journal of Molecular Sciences 22:17, pages 9339.
Crossref
Megan Maroney & Marija Markovic. 2021. 99 121 .
Adam Strzelczyk & Susanne Schubert-Bast. (2021) Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies. CNS Drugs 35:1, pages 61-83.
Crossref
Ana Matošević & Anita Bosak. (2020) Carbamate group as structural motif in drugs: a review of carbamate derivatives used as therapeutic agents. Archives of Industrial Hygiene and Toxicology 71:4, pages 285-299.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.